Does Aetna Cover Wegovy? Yes, some Aetna plans do cover Wegovy. Whether your plan will pay for it depends on your pharmacy benefit, the reason your clinician prescribed it, and the form you are filling out. Many plans will require prior authorization, and some employer plans will exclude weight loss drugs. Your member formulary and benefit terms are the best places to look to see what plans cover.
Does Aetna Cover Wegovy Under Your Plan?
Start with your pharmacy benefit on your Member ID card. If you have Aetna medical insurance and a separate Pharmacy Benefits Administrator, use the drug list and member services number for the Pharmacy Benefits Administrator. That team will be able to tell you what the rules are for your prescription.
| Plan type | Coverage question to ask | Prior authorization route |
|---|---|---|
| Employer-sponsored Aetna plan | Does the employer’s benefit include weight-management drugs? Is the prescribed form of Wegovy on your group’s formulary? | Your prescriber submits to the pharmacy benefits administrator if the plan requires it. |
| Stand-alone Aetna Medicare Part D plan | Is your prescription for a Part D-coverable use, such as reducing cardiovascular risk in eligible adults? For weight management, check the CMS Bridge separately. | Part D reviews requests for its benefit. The Bridge has its own authorization process. |
| Aetna Medicare Advantage with Part D | What does the plan’s prescription benefit cover for your indication? Eligible members can also check the Bridge for weight management. | Use the plan’s drug coverage rules or the Bridge process, depending on the indication. |
| Aetna Better Health Medicaid | Does your state’s Medicaid pharmacy benefit cover Wegovy for this use, and which drug list applies to you? | Your prescriber follows the state or managed-care plan’s drug criteria and submission instructions. |
Employer exclusions and state limitations
An example of a formulary that lists Wegovy with prior authorization and quantity limits is Aetna’s Advanced Control drug guide. Confirm the name of your group’s pharmacy plan. Just because you and your colleague have Aetna cards, does not mean you have the same prescription benefits. One employer may exclude obesity medications, while another includes them or covers a broader set of medications.
If you are told obesity medications are excluded, request the language used and check the scope. The exclusion may be for obesity medications for weight loss while coverage may be provided for obesity medications for a different condition, e.g. established cardiovascular disease.
If Medicaid is your payer, you will need to check separately. Find out what preferred drug list applies to your state and plan from Aetna Better Health, and ask for the policy for your condition. A state’s decision about obesity treatment tells you nothing about another state’s benefits or the rules for different diagnoses.
The reason for your prescription dictates the rules
Wegovy is a GLP-1 receptor agonist like Ozempic. Semaglutide is available in various formulations and for different indications. For an injection, Wegovy is approved for weight loss and Ozempic for weight loss and/or management. Wegovy is a higher-dose GLP-1 receptor agonist. For use in obesity, Wegovy is approved at a higher dose than Ozempic. Aetna’s clinical policies for pharmacy review the requested product and the diagnosis. Aetna has made coverage decisions for GLP-1 receptor agonists based on the desired dose and formulation.
Adjustment of Weight and BMI
According to the FDA label, the drug can be used for weight management in adults with obesity and adults with overweight with an associated health condition. Management typically requires reduction of caloric intake in combination with increased physical activity. Aetna then relies on the terms and conditions of your benefit plan and its clinical criteria to determine if Wegovy is medically necessary.
Aetna has published numerous non-Medicare criteria, and the one that would apply to you may vary based on your plan. Wegovy bulletin 4774-C states a baseline BMI of 30 or greater (or 27 or greater with a weight-related condition such as hypertension). A different weight-loss bulletin 6450-C states a baseline BMI of 35 or greater. Both of these criteria require evidence of participation in a comprehensive weight management program. The Pharmacy billing services teams can assist to verify which of these policies would apply and assist in identifying the records necessary to support the request for prior authorization.
The plan uses your starting BMI as the baseline for review. If you previously relied on medication to manage your weight, contact Aetna to find out what starting measurement they will use. Your height, weight and calculated BMI should be in your medical record. This may help the prescriber in advocating for a change in treatment or the continued need for treatment. Adolescents may be assessed by different criteria. For example, Aetna’s published criteria refers to a BMI at or above the 95th percentile for the patient’s age and sex.
Ask Aetna what type of weight management program they will cover. Clinical notes from nutrition counseling, behavioral support and physical activity planning may fulfill the documentation requirement. Participation records from a registered dietitian or structured weight management program may also provide sufficient documentation for the prescriber to complete a prior authorization request.
Cardiovascular risk reduction
Wegovy and the Wegovy tablets are approved by the FDA to reduce the risk of heart attack and stroke in adults with cardiovascular disease who are overweight or obese. An Aetna policy may require documentation of your baseline BMI being equal to or greater than 27, records of a qualifying event or vascular disease, and your cardiovascular treatment or why a recommended treatment is inappropriate. In addition, Aetna’s 4774-C example includes a restriction for type 2 diabetes in this pathway.
High blood pressure may be considered a weight-related condition in some weight management policies. The cardiovascular indication requires evidence of established disease. If your provider prescribed Wegovy to reduce your cardiovascular risk, ask the office to include the records that support that indication and use its related authorization criteria.
MASH with moderate to advanced liver fibrosis
The standard Wegovy injection is indicated by the FDA for the treatment of adults with noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH) and stage F2 or F3 fibrosis. Aetna has required a gastroenterologist or hepatologist to prescribe or consult, as well as document the fibrosis stage based on an accepted assessment, such as elastography or a liver biopsy. In the example, Wegovy HD is limited to adult weight management and the MASH pathway is applied to the standard Wegovy injection.
Aetna Medicare Part D and the Medicare GLP-1 Bridge
Aetna Medicare Part D and GLP-1 Bridge both have disease and drug-specific criteria. For Part D eligible uses (CV risk reduction or MASH for example), the member should present the prescription to the plan to determine if the drug is on the formulary and if the plan has criteria for the clinical situation. If the drug is not on the formulary for a Part D eligible use, the member should inquire about a formal coverage determination and whether the prescriber can support a formulary exception.
The Medicare GLP-1 Bridge is a separate CMS program for members with qualifying Part D coverage who have been prescribed a GLP-1 receptor agonist for weight management. CMS has included Wegovy (GLP-1 ra) pens and tablets on the program. The copay for each covered fill is $50. The Part D deductible will not apply to the fills and the copay will not apply to the member’s out of pocket spend for Part D.
Within the GLP-1 pathway, CMS uses the BMI to determine eligibility for some services and programs. For the CMS programs, thresholds include a baseline BMI of at least 35, at least 30 with a specific condition, such as Stage 3a or higher chronic kidney disease, at least 27 with a condition such as prediabetes or a prior stroke, and a treatment plan that includes structured nutrition and physical activity.
CMS guides members with type 2 diabetes, moderate to severe obstructive sleep apnea (OSA) or a qualified MASH condition to Part D to review coverage for GLP-1. If your prescription for Wegovy is for cardiovascular risk reduction, it will go to Part D for review even if the goal is weight management.
If your prescriber determines that you meet the criteria for the Bridge, the pharmacy needs to know which program the prescription is for. CMS directs the pharmacy to submit a Bridge claim to establish eligibility and to contact the prescriber for the prior authorization. The Bridge claim and prior authorization process are completed and then the weight management prescription can be routed to the Bridge.
How to get a Wegovy coverage decision from Aetna
1. Understand your drug listing
Use your Aetna Member account to look up your drug listing. If you do not have access to your Member account, you can use the Aetna Find a Medication tool with your pharmacy plan name, and look up the drug on your prescription to see the form, strength, and package.
PA, or prior authorization. If your drug requires a prior authorization, the plan will give you instructions on how to submit the prior authorization request with the required clinical information.
QL, or quantity limit. The plan specifies the maximum amount it is willing to pay per prescription.
ST, or step therapy. You may also need to provide evidence supporting an exception to the step therapy requirement.
Specialty designation. The plan will give you information on the specialty pharmacies that can dispense the drug through your benefit.
2. Confirm the indication and price
You can call the number on the back of your member card to ask about your coverage. “Can you check this Wegovy form and strength for the reason my clinician prescribed it? Is there an exclusion for that use? Which policy applies, and can you tell me the price at my pharmacy?” Have the name of your pharmacy available. Ask for the policy or plan section, and call reference number.
Include information about your pharmacy benefits and your deductible when generating a price estimate. Because deductibles are applied across the board, some plans provide a more favorable price at a preferred network pharmacy. Determine if the price estimate provided changes at preferred network pharmacies. If the representative can’t provide that information, find out where the indication restrictions are documented in the plan, if at all. Indication restrictions can save the prescriber from working off the wrong form.
3. Give the prescriber the records the plan needs
When a prior authorization request has been submitted, provide the prescribed records, strength, and quantity. In cases where the reason the clinician prescribed the drug falls under an indication other than the default, the prescriber should be prepared to submit documentation, and/or supporting paperwork that indicates the prescribed drug, strength, and quantity are appropriate. This documentation should also articulate the prescription in order to to satisfy the plan’s indication restrictions and policy. Based on the medical rationale, the plan may also require supporting documentation that describes the patient’s:
- Weight-related conditions
- Height and weight, and/or baseline BMI
- Weight management attempts and/or reasons other weight loss attempts are unsuitable
- This documentation should also indicate an appropriate attempt at step therapy.
- Order Specialist Notes, Cardiovascular Records, and/or Fibrosis Testing when indicated.
- Evidence of treatment response is required to justify continued coverage.
Ask the office to keep the submission confirmation and let you know which team is working the case. If the plan requests records, you’ll know if the missing item is in the prescriber’s chart, in another clinician’s chart, or in your program’s records.
4. Match the decision to the pharmacy claim
Upon approval, verify that the approval is based on the proper medication, dose, and quantity that is prescribed. In this case, the pharmacist will be able to process the prescription under the health insurance plan. If the claim gets rejected, then get the actual rejection message. The problem may be due to the use of a wrong member ID, NDC number, or dose. Medical billing services experts can analyze the reply from the pharmacy with the provider and payer.
Check the Wegovy medication on your prescription
Enter your pharmacy plan name and Wegovy strength to find the drug information and limitations. Take that information with you when you have your coverage call or appointment.
Coverage for refills and product changes
There are continuation rules for renewals. The Aetna bulletin 4774-C, for example, specifies a stable maintenance dose and an adult in the weight management pathway losing at least 5% of their baseline body weight and/or maintaining that loss. Rules for adolescent and non-weight indications are also included. Ask the office what weight, BMI, or clinical response the plan is looking for in your case.
Keep your baseline measurement, approval and response documentation. Case examples are often illustrative. In one example, a member with a baseline BMI of 36 and a baseline weight of 246 pounds with a loss to a BMI of 33 and a weight of 234 pounds could look ineligible for continued coverage if a new request only cites a BMI of 33. In this case, the member should have also submitted the baseline BMI and weight of 36 and 246, respectively, to support their request for continued coverage.
Check if a new authorization is needed for a change in dose form, i.e. tablet to injection, a different employer’s plan, or strength. The pharmacist can tell you what product and dose is being billed and the pharmacy benefits administrator can tell you if that is in line with the approval. Your prescriber can assist you with a change in treatment.
Wegovy denials and appeals
Request the written decision and the policy or benefit provision to understand the rationale. The pharmacist can often give a reason for a claim denial. The pharmacy benefits administrator can give a rationale for denials and determinations. The plan’s written decision can give you information on next steps and your level of appeal.
| Reason you’re given | Action that addresses it |
|---|---|
| Prior authorization required or missing | Ask the prescriber to confirm where the request went and whether the plan has it under your member ID. |
| Clinical criteria unmet or documentation incomplete | Get the specific criterion. If the office has evidence the plan didn’t receive, ask about a corrected submission or include the records in an appeal. |
| Drug is nonformulary or step therapy applies | Ask whether the plan accepts a formulary or step-therapy exception. Your clinician can explain why the covered options are unsuitable, if that’s supported by your record. |
| Weight-management drugs are excluded | Request the exact exclusion. Check whether it applies to the diagnosis and product being reviewed. If it applies, discuss options that fit the benefit with your clinician and benefits team. |
Focus your appeal on the written reasons
You must follow the filing instructions on the denial notice. Also, you must cite the determination, provide the name of the drug requested and the reason for the request, and indicate the policy provision being disputed, and provide a short explanation to support your request. Keep the confirmation of the submission and notice. The plan may say it has no baseline BMI, and an office note, with measured height and weight, is more helpful than a letter stating Wegovy is medically necessary.
There are several things to consider in your employer plan, if it does not provide drug coverage for weight management, and your BMI is 37. A medical necessity letter explains your clinical eligibility. You would need to determine if the plan excluded coverage for the drug for weight loss management. If a plan incorrectly stated it would provide coverage for Wegovy, you would need to ask the plan to review the incorrect statement. If the plan states it excluded coverage for the drug for weight loss management, you would need to see if your clinician can provide a justification for the use of a different benefit.
The plan documents or notice should indicate what type of review you are being offered. Many commercial plans say they will provide both an internal review and an external independent review. Check with your employer’s plan administrator for your employer sponsored plan. For a Part D appeal you will need to contact the plan for a redetermination. A Medicaid denial would allow you to do a managed care appeal and a state fair hearing. If your clinician states standard review would be detrimental to your health, you should ask the plan for an expedited review. For a denied Bridge authorization, CMS states the prescriber can re-file with updated or additional information.
Wegovy Prices with and without Aetna Coverage
With Insurance
Aetna doesn’t have a single Wegovy price. Your pharmacy benefit may have a fixed copay or coinsurance, which is a percentage of the plan’s allowed price. If you have a remaining drug deductible, you may owe some or all of the negotiated price for that fill. Check the drug tier, deductible and cost at the pharmacy you plan to use.
Using the example above, if a plan’s allowed amount is $400, and the member owes 25% coinsurance with the deductible met, their share would be $100. These numbers are illustrative. Your estimate should be for the actual product and package. If the pharmacy price and/or the portal estimate are different, ask if the claim applied the deductible and/or if the network rate was different.
Paying Cash or using a Savings Offer
Novo Nordisk’s published list price is the manufacturer’s list price. The pharmacy’s cash price and Novo Nordisk’s self pay price can be different from the manufacturer’s list price. Self pay examples for Wegovy range from $149 to $299 for the tablets depending on strength, and standard Wegovy pens range from $349 to $399. Self pay HD Wegovy pens range from $499 to $599. Check offer terms and the pharmacy’s quote for the prescribed strength.
For those with eligible commercial insurance for Wegovy, NovoCare has advertised a copay of $25, with savings capped at $100 per eligible carton or bottle. As stated by multiple sources, a higher copay can result in an amount due greater than $25. The commercial copay offer does not extend to Medicare, Medicaid or other government sponsored plans. NovoCare’s separate home delivery self-pay offer can extend to those with government coverage, if that offer is accepted. Cash purchases are outside of the insurance benefit and do not impact the yearly deductible or out-of-pocket limit.
If you use a pharmacy discount card, have the pharmacist compare that price to the price with insurance for the same package. Ask your plan how it treats the payment. If you are making a cash purchase, and an authorization for your prescription has not been resolved, ask the pharmacy if it can rebill the claim. The answer to the same question should be asked of your plan, if it is accepting a request for reimbursement. Reimbursement is dependent on the plan’s rules and policies and how the claim is ultimately processed.
Other weight loss medications to consider include
Bariatric (Weight loss) surgery is not included in this analysis, but is an important consideration for patients with morbid obesity.
Consider alternatives in your diagnosis and check formulary tiers. If the insurance plan excludes weight management medications, check if the exclusion also includes the alternative medication being considered.
| Medication | What to confirm with the plan |
|---|---|
| Zepbound (tirzepatide) | Check the listing for weight management. It also has a separate FDA-approved use for moderate to severe obstructive sleep apnea in adults with obesity, with coverage criteria tied to that indication. |
| Saxenda or a weight-management generic (liraglutide) | Check which version the plan prefers and whether it requires prior authorization. Liraglutide products can carry different approved uses. |
| Foundayo (orforglipron) | This is an oral GLP-1 option for eligible adults. Ask whether the plan lists it for weight management and which restrictions apply. |
| Orlistat | This is a non-GLP-1 option. Check the exact product because coverage for a prescription and an over-the-counter formulation can differ. |
Ozempic and Wegovy both contain semaglutide. Each has its own FDA labeling and coverage criteria. If Aetna lists Ozempic under a diabetes benefit, ask your clinician which product fits your diagnosis and ask the plan to verify that product’s coverage. If you see a low cash price for compounded semaglutide, confirm what is being offered with your pharmacist. Compounded drugs fall outside the FDA’s drug approval process for safety, effectiveness, and quality.
For an individual plan response
Member ID and prescription information should be available. Request from the pharmacy benefits department whether the same fill will be covered, approved, and cost estimate.
Frequently asked questions
Does Aetna cover Wegovy for weight loss?
Yes, when your plan includes the benefit and you meet its requirements. Look for your prescribed Wegovy form and check for a weight-loss drug exclusion. If the plan requires prior authorization, your prescriber submits records that address the clinical criteria.
What BMI does Aetna require for Wegovy?
It depends on the plan and indication. For adult weight management, one published Aetna policy uses a baseline BMI of 30 or higher, or 27 or higher with a qualifying condition. Another uses 35 or higher. Ask which policy applies to your prescription.
Does Aetna require prior authorization for Wegovy?
In many plans, yes. Look for a PA flag in your formulary and confirm the requirement with the pharmacy benefits team. Your prescriber can submit the diagnosis and supporting records the plan requests.
Does Aetna Medicare cover Wegovy?
An Aetna Medicare drug plan may cover Wegovy for a Part D-coverable use, such as cardiovascular risk reduction in eligible adults. For weight management, eligible members can ask about the separate CMS Medicare GLP-1 Bridge and its $50 copay per covered fill.
How much does Wegovy cost with Aetna insurance?
Your cost depends on your plan’s deductible, copay or coinsurance, the Wegovy product, and the pharmacy. Use Aetna’s member cost estimator or call the pharmacy number on your card for a quote tied to the exact prescription.
What can I do if Aetna denies Wegovy?
Get the written reason. Missing records may call for a corrected submission. A formulary restriction may have an exception process. If you dispute the determination, follow the appeal instructions in the notice and submit records that address the cited reason.
Get your answer to your prescription
Will Wegovy be covered under Aetna? Provide the pharmacy benefit group with details on the drug itself and the reason behind why it was prescribed to you. Get the policy in writing to help make an informed decision about submitting claims or appealing the coverage decision.
